Medulloblastoma (MB) is an aggressive embryonal brain tumor affecting the posterior fossa and is classified into four molecular subgroups: Shh, Wnt, Group 3, and Group 4 [1], with each subgroup displaying distinct genomic features, transcriptional profiles, clinical presentation, and prognosis [2]. The gene discussed is SHH; the disease is medulloblastoma.